Global pharma reach Cisiv serves 90% of the top global pharmaceutical companies and supports 200+ projects, indicating a strong potential to upsell platform modules such as EDC, eConsent, and ePRO to large enterprise clients and expand footprints with existing relationships.

Cost efficiency driver Baseline Plus claims to reduce data management costs by 60%, a compelling value proposition for mid to large pharma and biotech customers seeking efficiency gains, which can be highlighted in ROI-focused conversations.

Modular platform The platform’s modular, highly configurable architecture supports site-based, decentralized, and hybrid studies, enabling targeted conversations with CROs and sponsor teams pursuing flexible, compliant real-world data collection.

Sustainability & safety focus By enabling comprehensive safety and efficacy real-world data collection across global studies, Cisiv positions itself to address pharmacovigilance, post-market surveillance, and continuous safety monitoring needs faced by pharma and medical device clients.

Growth-ready tech stack With a platform used by large pharma and a tech stack that includes modern tools and AI capabilities, Cisiv can target customers seeking scalable, cloud-based data platforms and potential AI-driven analytics or automation enhancements.